Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Showing content from https://pubmed.ncbi.nlm.nih.gov/34349563/ below:

Delayed Breast Cancer Detection in an Asian Country (Taiwan) with Low COVID-19 Incidence

Affiliations

• ¹ Department of Radiology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.
• ² Department of Medical Laboratory Sciences and Biotechnology, Fooling University, Kaohsiung, 807, Taiwan.
• ³ Department of Nursing, Shu-Zen Junior College of Medicine and Management, Kaohsiung, Taiwan.
• ⁴ Department of Health-Business Administration, School of Nursing, Fooyin University, Kaohsiung, Taiwan.

• PMID: 34349563
• PMCID: PMC8326285
• DOI: 10.2147/CMAR.S314282

Item in Clipboard

Chen-Pin Chou et al. Cancer Manag Res. 2021.

• ¹ Department of Radiology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.
• ² Department of Medical Laboratory Sciences and Biotechnology, Fooling University, Kaohsiung, 807, Taiwan.
• ³ Department of Nursing, Shu-Zen Junior College of Medicine and Management, Kaohsiung, Taiwan.
• ⁴ Department of Health-Business Administration, School of Nursing, Fooyin University, Kaohsiung, Taiwan.

• PMID: 34349563
• PMCID: PMC8326285
• DOI: 10.2147/CMAR.S314282

Item in Clipboard

Purpose: To assess whether the COVID-19 pandemic delayed breast cancer diagnosis in Taiwan, an Asian country with a low COVID-19 incidence.

Methods: The monthly volume of breast biopsies and breast cancers during the COVID-19 pandemic (during January 21 and July 31, 2020) was compared to the same period in 2019 (pre-COVID-19).

Results: Taiwan recorded a lower COVID-19 incidence rate (20.2 cases per million population) than other Asian countries. The screen-detected lesions accounted for 55% and 36% of 2019 and 2020 total biopsied lesions, respectively. Total breast biopsy, mammography-guided, and ultrasound-guided biopsies decreased by 17%, 23%, and 14%, respectively, from pre-COVID-19 to COVID-19. Monthly differences were significant in total biopsy (p=0.03), mammography-guided biopsy (p=0.04), and a benign pathology result after breast biopsy (p<0.01). Nearly 46% decline was noted in the biopsy results of non-invasive breast cancer in 2020. The number of total breast cancers and early breast cancers (stages 0 and 1) decreased by 10% and 38%, respectively, during pandemic. Individuals with early breast cancer accounted for 71% and 49% of the total diagnosed breast cancer in the pre-COVID-19 and COVID-19 periods, respectively (p<0.001).

Conclusion: The pandemic significantly delayed early breast cancer detection in Taiwan despite low COVID-19 incidence.

Clinical trial registration: ClinicalTrials.gov, NCT04750018.

Keywords: COVID-19; breast biopsy; breast cancer; mammography; pandemic.

© 2021 Chou and Lin.

PubMed Disclaimer

Chen-Pin Chou and Huey-Shyan Lin have no conflict of interest.

Monthly trend in the number…

Monthly trend in the number of breast biopsy procedures and breast cancer cases…

Monthly trend in the number of breast biopsy procedures and breast cancer cases in the periods of 2019 (Pre-COVID-19) and 2020 (COVID-19). A reference map shows a total number of confirmed COVID-19 cases (including imported and indigenous cases) in Taiwan by months.

Correlation between new monthly COVID-19…

Correlation between new monthly COVID-19 cases (N=466) and monthly difference of confirmed breast…

Correlation between new monthly COVID-19 cases (N=466) and monthly difference of confirmed breast cancer cases between 2019 (N=128) and 2020 (N=115).

Percentage change of the number…

Percentage change of the number in breast cancer staging categories (stage 0–4) from…

Percentage change of the number in breast cancer staging categories (stage 0–4) from pre-COVID-19 to COVID-19.

• Breast Biopsy Recommendations and Breast Cancers Diagnosed during the COVID-19 Pandemic.

  Lowry KP, Bissell MCS, Miglioretti DL, Kerlikowske K, Alsheik N, Macarol T, Bowles EJA, Buist DSM, Tosteson ANA, Henderson L, Herschorn SD, Wernli KJ, Weaver DL, Stout NK, Sprague BL. Lowry KP, et al. Radiology. 2022 May;303(2):287-294. doi: 10.1148/radiol.2021211808. Epub 2021 Oct 19. Radiology. 2022. PMID: 34665032 Free PMC article.

• Characteristics of breast cancers detected by screening mammography in Taiwan: a single institute's experience.

  Han HJ, Chu YC, Wang J, Lai YC, Tseng LM, Huang CC. Han HJ, et al. BMC Womens Health. 2023 Jun 21;23(1):330. doi: 10.1186/s12905-023-02445-6. BMC Womens Health. 2023. PMID: 37344800 Free PMC article.

• Breast cancers detected by breast MRI screening and ultrasound in asymptomatic Asian women: 8 years of experience in Taiwan.

  Cheng YC, Wu NY, Ko JS, Lin PW, Lin WC, Juang SJ, Tsai TT, Chang CY, Chen JH, Cheng HC. Cheng YC, et al. Oncology. 2012;82(2):98-107. doi: 10.1159/000335958. Epub 2012 Feb 11. Oncology. 2012. PMID: 22328009

• Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in women at average risk.

  Glechner A, Wagner G, Mitus JW, Teufer B, Klerings I, Böck N, Grillich L, Berzaczy D, Helbich TH, Gartlehner G. Glechner A, et al. Cochrane Database Syst Rev. 2023 Mar 31;3(3):CD009632. doi: 10.1002/14651858.CD009632.pub3. Cochrane Database Syst Rev. 2023. PMID: 36999589 Free PMC article. Review.

• A systematic review of the impact of the COVID-19 pandemic on breast cancer screening and diagnosis.

  Li T, Nickel B, Ngo P, McFadden K, Brennan M, Marinovich ML, Houssami N. Li T, et al. Breast. 2023 Feb;67:78-88. doi: 10.1016/j.breast.2023.01.001. Epub 2023 Jan 5. Breast. 2023. PMID: 36646004 Free PMC article. Review.

• Impact of COVID-19 and Socioeconomic Factors on Delays in High-Risk MRI Breast Cancer Screening.

  Teng H, Dang W, Curpen B. Teng H, et al. Tomography. 2022 Aug 27;8(5):2171-2181. doi: 10.3390/tomography8050182. Tomography. 2022. PMID: 36136878 Free PMC article.

• Impact of the COVID-19 pandemic on population-based cancer screening, a nationwide retrospective study in Taiwan.

  Su CH, Hsu PS, Lin CS. Su CH, et al. BMC Health Serv Res. 2023 Aug 21;23(1):878. doi: 10.1186/s12913-023-09901-x. BMC Health Serv Res. 2023. PMID: 37605162 Free PMC article.

• How Taiwan has responded to COVID-19 and how COVID-19 has affected Taiwan, 2020-2022.

  Lai CC, Lee PI, Hsueh PR. Lai CC, et al. J Microbiol Immunol Infect. 2023 Jun;56(3):433-441. doi: 10.1016/j.jmii.2023.04.001. Epub 2023 Apr 6. J Microbiol Immunol Infect. 2023. PMID: 37061349 Free PMC article. Review.

• Radiogenomic Landscape of Metastatic Endocrine-Positive Breast Cancer Resistant to Aromatase Inhibitors.

  Khanyile R, Chipiti T, Hull R, Dlamini Z. Khanyile R, et al. Cancers (Basel). 2025 Feb 26;17(5):808. doi: 10.3390/cancers17050808. Cancers (Basel). 2025. PMID: 40075655 Free PMC article. Review.

• Impact of the Sars-Cov-2 outbreak on the initial clinical presentation of new solid cancer diagnoses: a systematic review and meta-analysis.

  Marty S, Lamé G, Guével E, Priou S, Chatellier G, Tournigand C, Kempf E; a CRAB* initiative. Marty S, et al. BMC Cancer. 2024 Jan 29;24(1):143. doi: 10.1186/s12885-023-11795-1. BMC Cancer. 2024. PMID: 38287348 Free PMC article.

1. 1. Cheng HY, Jian S-W, Liu D-P, et al. Contact tracing assessment of COVID-19 transmission dynamics in taiwan and risk at different exposure periods before and after symptom onset. JAMA Intern Med. 2020;180(9):1156–1163. doi:10.1001/jamainternmed.2020.2020 - DOI - PMC - PubMed
2. 1. Wang CJ, Ng CY, Brook RH. Response to COVID-19 in Taiwan: big data analytics, new technology and Proactive Testing. JAMA. 2020;323(14):1341–1342. - PubMed
3. 1. Chang HJ, Huang N, Lee C-H, et al. The impact of the SARS epidemic on the utilization of medical services: SARS and the fear of SARS. Am J Public Health. 2004;94(4):562–564. doi:10.2105/AJPH.94.4.562 - DOI - PMC - PubMed
4. 1. Chou CP, Pan H-B, Hsu G-C, et al. Assessing the first 3 years of Taiwan’s nationwide population-based mammography screening program. Breast J. 2012;18(5):498–499. doi:10.1111/j.1524-4741.2012.01289.x - DOI - PubMed
5. 1. Yen AM, Tsau HS, Fann JC, et al. Population-based breast cancer screening with risk-based and universal mammography screening compared with clinical breast examination: a propensity score analysis of 1429890 Taiwanese women. JAMA Oncol. 2016;2(7):915–921. doi:10.1001/jamaoncol.2016.0447 - DOI - PubMed

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.3